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Abstract
Background: The optimal range of relative weight for morbidity and mortality in Asian populations is an important question
in need of more thorough investigation, especially as obesity rates increase. We aimed to examine the association between
body mass index (BMI), all cause and cause-specific mortality to determine the optimal range of BMI in relation to mortality
in Chinese men and women in Singapore.
Methodology/Principal Findings: We analyzed data from a prospective cohort study of 51,251 middle-aged or older (45–
74) Chinese men and women in the Singapore Chinese Health Study. Participants were enrolled and data on body weight
and covariates were collected in 1993–1998 and participants were followed through 2008. The analysis accounted for
potential methodological issues through stratification on smoking and age, thorough adjustment of demographic and
lifestyle confounders and exclusion of deaths early in the follow-up.
Conclusions/Significance: Increased risk of mortality was apparent in underweight (,18.5) and obese BMI categories
($27.5) independent of age and smoking. Regardless of age or BMI, smoking considerably increased the rate of mortality
and modified the association between BMI and mortality. The most favorable range of BMI for mortality rates and risk in
non-smoking persons below age 65 was 18.5–21.4 kg/m
2, and for non-smoking persons aged 65 and above was 21.5–
24.4 kg/m
2.
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Introduction
The prevalence of obesity continues to increase in developed
and developing Asian nations, and the rates of chronic disease
have mirrored this trend. [1] With increasing global obesity trends,
heightened attention has been paid to the relation between body
weight and mortality. Many studies on this topic, mostly on
Western populations, have produced somewhat divergent results.
[2] However, a recent analysis of over 900,000 adults primarily
from prospective cohorts of Western populations found that the
most favorable Body Mass Index (BMI) range in relation to the
lowest all-cause mortality rate is 22.5 to 25.0 kg/m
2. [3] By
contrast, inconsistent associations have been observed in the few
prospective Asian studies that have been reported. [4–9]
There are multiple methodological considerations in the study
of body weight and mortality. The great majority of studies have
used BMI (kg/m
2), which is a reasonable and easily applicable
surrogate measure of adiposity in populations, [10,11] but subject
to criticism. [12] The main methodological issues beyond the
measure of adiposity focus on accounting for the anorectic effects
of cigarette smoking, [13,14] confounding due to prevalent and
antecedent disease, [14–16] control of intermediate variables in
the causal pathway, [10,14] and how age may modify the
association. [14] For example, BMI is a less reliable marker of
adiposity due to differential loss of muscle and bone mass in
persons aged 65 years and above. [14,17]
The investigation of BMI and mortality in Asians presents an
intriguing study due to the larger proportion of the population
with low BMI’s, and research on Asian populations is compara-
tively sparse. Furthermore, South/Southeast Asians appear to be
distinctive anthropometrically compared with Western popula-
tions; with lower BMI’s, but higher body fat percentages
comparable to World Health Organization (WHO) BMI strata
for overweight or obesity in Western populations, and greater
abdominal and visceral fat deposition. [18–20] Thus, the
discussion of an optimal weight range or the most favorable
BMI-range in relation to the lowest mortality rate and risk in Asian
populations is distinct from the discussion on Western populations.
The Singapore Chinese Health Study (SCHS) is a prospective
cohort investigation of diet and cancer in 63,257 Chinese men and
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potential methodological issues through stratification on smoking
and age, thorough adjustment of demographic and lifestyle
confounders, and exclusion of prevalent disease and early deaths.
Therefore, the aim of this study was to examine the association
between BMI and all-cause and cause specific mortality using the
aforementioned methodological approaches to determine the
optimal range of BMI in a large sample of Chinese men and
women living in Singapore.
Methods
Study Population
The design of the Singapore Chinese Health Study has been
previously described. [20] Briefly, the cohort was drawn from men
and women, aged 45 to 74 at enrollment, who belonged to one of
the major dialect groups (Hokkien or Cantonese) of Chinese in
Singapore. Between April 1993 and December 1998, 63,257
individuals completed an in-person interview that included
questions on demographics, educational attainment, height,
weight, use of tobacco and alcohol, usual physical activity,
menstrual and reproductive history (women only), medical history,
family history of cancer and a 165-item food frequency section
assessing usual dietary intake of the previous year. The
institutional review boards at the National University of Singapore
and the University of Minnesota approved this study. Written
informed consent was obtained from all participants.
Exposure Assessment
Self reported height and weight were collected at the baseline
interview. BMI was calculated as weight (kg) divided by height
squared (m). Self-report of body weight and height has been shown
to be highly valid across many populations [10], as well as
specifically in Asians. [21] Age was defined as age in years at the
time of the baseline examination. Education was categorized into
no formal education, primary school, and secondary school or
above. Cigarette smoking was classified into never smoker, former
smoker, and current smoker as described previously. [22]
Participants reporting a history of physician diagnosed cardiovas-
cular disease, diabetes, or respiratory disease at baseline were
classified as having a history of prevalent disease for the present
analysis. Physical activity was assessed as the amount of time spent
doing strenuous sports (e.g. jogging) and moderate activity (e.g.
brisk walking) in a week, but due to low activity levels in the
population, participants reporting any strenuous sporting activity
or moderate activity were combined for the present analysis.
A semi-quantitative food frequency questionnaire specifically
developed for this population assessing 165 commonly consumed
food items was administered during the baseline interview. The
questionnaire has subsequently been validated against a series of
24-hour dietary recall interviews, [20] as well as selected
biomarkers. [23,24] Dietary patterns were derived for this study
population using principal component analysis including all 165
foods and beverages as described previously. [25] Briefly, the aim
of PCA in nutritional analyses is to account for the maximal
variance of dietary intake by combining the many different dietary
variables into a smaller number of factors based upon the
intercorrelations of these variables. A vegetable, fruit, and soy rich
pattern characterized by high intake of those respective foods and
lower intake of meats, dim sum, western fast food and soft drinks
was included as a covariate. Frequency of alcohol intake as the
summation of beer, rice wine, other wine and hard liquor was
considered as an individual variable and grouped as nondrinker/
monthly drinker, weekly drinker, and daily drinker.
Assessment of Mortality
Information on date and cause of death was obtained through
linkage analysis with the nation-wide registry of birth and death in
Singapore. Up to six different international classification of disease
codes version 9 (ICD-9) were recorded in the registry. Primary
cause of death was used for analysis. Vital status for cohort
participants was updated through December 31, 2008. As of April
2008 only 27 persons were lost to follow up due to migration out of
Singapore, suggesting that emigration of the cohort participants
was negligible and that vital statistics follow up was virtually
complete.
The end points in our cause-specific analyses were deaths from
cardiovascular disease (codes 394.0–459.0), ischemic heart disease
(410.0–414.9, 427.5), and cerebrovascular disease (430.0–438.0),
all cancers (140.0–195.8 and 199–208.9), and excess weight
related cancers. Specific cancer sites related to excess weight
included esophagus (150.0–150.9), stomach (151.0–151.9), colon
(153.0–153.9), liver (155.0–155.2), gallbladder (156.0–156.9),
pancreas (157.0–157.9), female breast (174.0–174.9), cervix and
corpus uteri (179, 182.0–182.8), ovary (183.0–183.9), prostate
(185), and kidney (189.0–189.9).
Statistical Analysis
Of the original 63,257 participants, we excluded 1,936 subjects
with a history of invasive cancer (except non-melanoma skin
cancer) or superficial, papillary bladder cancer at baseline since
they did not meet study inclusion criteria, and 10,070 participants
missing either or both height and weight measures. The present
analyses included 51,251 participants. Participants excluded due
to missing BMI (N=10,070) were not materially different across
the noted demographic and lifestyle characteristics according to
smoking status compared to participants with full data and
included in the analysis (51,251).
Study participants were grouped according to 8 categories of
BMI, as reported at the baseline interview (,18.5, 18.5–19.9,
20.0–21.4, 21.5–22.9, 23.0–24.4, 24.5–25.9, 26.0–27.4, $27.5).
These categories were created to allow for a detailed examination
of the association between BMI and all-cause and cause-specific
mortality based on the distribution of BMI in the study population
with the consideration of BMI cut points recommended by the
World Health Organization (WHO) working group for Asian
populations (BMI,18.5=underweight, 18.5–22.9=normal
weight, 23.0–27.4=overweight, $27.5=obese). [26] We further
separated individuals with BMI’s,18.5 into the BMI groups of
17.0–18.4 and ,17.0 to examine the low end of the BMI
spectrum. For each study subject, person-years were counted from
the date of baseline interview to the date of death, date of last
contact (for the few subjects who migrated out of Singapore) or
December 31, 2008, whichever occurred first. Baseline character-
istics were calculated for participants across each category of BMI.
Age and sex standardized mortality rates were calculated using the
person-year weight of the entire cohort during the follow-up by the
following age categories: (,50, 50–54, 55–59, 60–64, 65–69, 70+).
Proportional hazards (Cox) regression methods were used to
examine the associations between BMI and hazard risk of death.
All regression analyses were conducted using SAS statistical
software version 9.1 (SAS institute, Cary, NC). We estimated the
hazard ratio (HR) of death for levels of BMI and the
corresponding 95% confidence interval (CI). There was no
evidence that proportional hazards assumptions were violated as
indicated by the lack of significant interaction between BMI and a
function of survival time in the models. The referent BMI category
was chosen based on the lowest age and sex standardized mortality
rate. Our primary Cox regression model included the following
BMI and Mortality: SCHS
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2), sex, year of interview
(1993–95 and 1996–98), dialect (Hokkien vs. Cantonese), level of
education (no formal schooling, primary school, secondary school
or above), any moderate or strenuous physical activity (yes vs. no),
and quintile of vegetable, fruit, and soy rich dietary pattern score.
In smokers we further adjusted for number of cigarettes smoked
per day and number of years of smoking over lifetime, plus
duration of time quit in non-smokers. The presence of a quadratic
BMI-mortality association (the U or J-shaped curve) was examined
by including a quadratic term of the median BMI value within
each BMI category in the Cox regression models. Separate
product terms of smoking, prevalent disease, age and sex with BMI
were included in Cox regression models to examine potential
interactions. To reduce potential bias due to preexisting disease or
illness-related weight loss, all analyses were repeated after
excluding subjects with reported prevalent disease (CVD, diabetes,
respiratory) at baseline and mortality incidence within the first 5
years post-enrollment. Alcohol intake as an independent variable
did not predict risk of death alone or in combination with a dietary
pattern score not encompassing alcohol intake, so it was not
included in the final regression model for the present analysis.
Further text and figures from a non-parametric (local polynomial)
regression analysis can be found in File S1.
Results
Baseline characteristics of the study participants according to
eight categories of BMI by smoking status are presented in
Table 1. There is evidence that the relation between BMI and
mortality in smokers and non-smokers differs in important ways (P
interaction between smoking and BMI=0.0012). Hence, results
are stratified by smoking status category. Population trends show
males smoked at significantly higher levels than females in the
study population, as 86% of ever-smokers were male. Greater
education, physical activity and a higher vegetable, fruit, and soy
rich dietary pattern score all had a significant inverse association
with mortality.
In 9,777 current smokers with a mean follow up of 11.8 years,
there were 2,762 deaths. There is a statistically significant
quadratic association between BMI and all-cause mortality in
current smokers with the lowest age and sex standardized
mortality rate among those with BMI’s 26–27.4 as presented in
Table S1. In 5,708 ex-smokers, during a mean 11.6 years of
follow up there were 1,423 deaths. The lowest standardized
mortality rate was among those with BMI’s 23–24.4 and a
significant quadratic association between BMI and risk of
mortality is observed. In 35,766 non-smokers (4,590 with reported
prevalent disease), during a mean follow up of 12.7 years, there
were 4,171 deaths. The lowest age and sex standardized mortality
rate is observed in BMI’s 18.5–19.9 kg/m
2 and risk increases at
BMI’s.26.0 and ,18.5.
The remaining results presented on cause-specific and stratified
analyses are focused on non-smokers who did not report a
surveyed chronic disease or health condition at baseline nor died
within five years. This analytic approach may best inform on the
optimal relative weight range for public health purposes; [14] or
the most favorable BMI-range in non-smokers in relation to the
lowest mortality rate and risk.
Cause-specific analyses examining total cardiovascular disease
(CVD) mortality and cancer mortality are presented in Figure 1.
We further examined components of CVD mortality in ischemic
heart disease (IHD) (ICD-9 410–414, 427.5) and found risk
significantly increased at BMI’s.26.0 (p=0.019 for linear
association); and for cerebrovascular disease (CERE) mortality
(ICD-9 430–438) risk increased at BMI’s.27.5 (p=0.04 for linear
association) (data not presented). Comparatively, the absolute
number of deaths, and the age and sex standardized mortality
rates per 10,000 person years of follow up were significantly higher
across the spectrum of BMI for ischemic heart disease vs.
cerebrovascular disease (IHD rates- 10, 6, 7, 10, 8, 9 11,12 and
CERE rates- 4, 3, 6, 6, 6, 5, 6, 8) for BMI groups (,18.5, 18.5–
19.9, 20.0–21.4, 21.5–22.9, 23.0–24.4, 24.5–25.9, 26.0–27.4,
$27.5). In consideration of excess weight-related cancer mortality,
an increased risk was observed at BMI’s$27.5, HR=1.50, 95%
CI (1.02–2.20).
All-cause and cause-specific data from examination of the low
end of the BMI spectrum is presented in Figure 2. Data from an
age-stratified analysis is presented in Figure 3. There is
physiological rationale for age stratification as well as statistical
evidence that the association differed for persons aged 65 and
greater (P=0.0001 for age 6 BMI interaction). The lowest age
and sex-standardized all-cause mortality rate for ages 65 and
greater is in BMI’s 23–24.4, shifting the nadir of the BMI-
mortality curve to the right relative to persons aged ,65 at
baseline. Cause-specific age stratified analyses show that the nadir
of the curve did not shift in any of the cardiovascular related
mortality groups (BMI=18.5–19.9). However, for persons aged 65
or greater the lowest rate for cancer shifted to BMI’s 23–24.4.
Data on specific risks are not presented for age-stratified cause-
specific analyses due to small numbers causing unstable estimates.
Excluding extreme BMI’s (,15.5 and .35.0) did not alter the
results in any specific analysis; nor was there any evidence the
association differed by sex (P interaction=0.36) across analyses.
However, men had higher age standardized mortality rates per
10,000 person years of follow up in current, ex and non-smokers.
In Figure S1 data from a sex stratified analysis is presented and
the shape and nature of the association largely mirrors the main
results. A further examination of the shape of the association
between BMI and mortality is presented in non-parametric graphs
in File S1. These results provide visual evidence for the nature
and shape of the association using different modeling assumptions.
Discussion
In this large prospective study of men and women Chinese
Singaporeans, aiming to inform on the optimal BMI range in
relation to mortality for public health recommendations, we
observed markedly greater mortality rates by BMI group in ex and
current smokers compared to non-smokers. In non-smokers the
lowest all-cause mortality rate was in BMI’s 18.5–19.9 and risk of
mortality significantly increased at BMI’s,18.5 and $26.0. In ex-
smokers the nadir of the BMI-mortality curve shifted right with the
lowest all-cause mortality rate in BMI’s 23.0–24.4 with similar
points of increased risk as non-smokers. Among current smokers
the nadir of the BMI-mortality curve shifted further right on the
BMI spectrum with the lowest rate of all-cause mortality in BMI’s
26.0–27.4 and associations of increased risk at BMI’s,23.0 and
$27.5. In cause-specific analyses examining total CVD mortality
in non-smokers risk increases at BMI’s$20.0 and also at
BMI’s,18.5, and risk of cancer mortality increases at
BMI’s$27.5. Sex stratified analyses show largely similar results
between sexes, although men have higher mortality rates across
analyses. Investigation of the low end of the BMI spectrum in non-
smokers suggests that participants with BMI’s,17.0 drive the
increased risk in the WHO underweight category (,18.5). In
analyses stratified by age, the lowest mortality rate and risk for
adults less than 65 years of age is in BMI’s 18.5–21.4 kg/m
2;
although the increases in risk for BMI values 21.5–27.5 are
BMI and Mortality: SCHS
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mortality is in BMI’s 21.5–24.4 kg/m
2. Independent of smoking
and age, obesity status (BMI$27.5) is clearly associated with
increased risk for mortality, as is underweight status (BMI’s,18.5).
The associations observed for CVD mortality are similar to
what we and others have reported for BMI, diabetes and CVD
risk, where values in the normal range of BMI associate with
increasing risk. [10,27] The risk of death from cancer and excess
weight related cancers increased similarly in obese participants
(BMI$27.5 at enrollment). Overall, counts of cancer related
mortality were greater and standardized mortality rates were
slightly greater compared to cardiovascular disease. Substantial
evidence supports the biologic plausibility of excess weight as a
major risk factor in hastening chronic disease and thus risk for
death. [10,28–30] Indeed, the biological plausibility and negative
effects of low BMI and health conditions and mortality have also
been documented. [17].
Our results showing overweight ex-smokers (BMI=23–24.4)
and current smokers who were nearly obese (BMI=26–27.4), as
having the lowest rates of mortality relative to other ex and current
smokers, is an under-studied topic. These results suggest over-
weight status in person with a history of smoking may be protective
relative to being under and normal weight or obese. However, due
to the lack of clinical data and complete health status
interpretation should be cautious. We have observed a similar
situation in relation to smoking and lung cancer in this cohort
Table 1. Baseline characteristics by smoking status according to body mass index (BMI) in SCHS.
Body Mass Index (kg/m
2)
Characteristics ,18.5 18.5–19.9 20.0–21.4 21.5–22.9 23.0–24.4 24.5–25.9 26.0–27.4 $27.5
Non-smokers, N=35,766
N 2,260 3,612 5,643 6,422 6,210 4,779 2,937 3,903
Age 55.5 (8.1) 54.8 (7.7) 54.8 (7.8) 54.9 (7.7) 55.1 (7.6) 55.4 (7.7) 55.3 (7.7) 55.6 (7.8)
Sex (% women) 75.7 76.0 72.1 71.5 68.9 70.2 67.3 74.6
Weight (kg) 44.0 (5.0) 48.5 (4.7) 52.4 (5.1) 55.9 (5.4) 59.7 (5.7) 63.1 (6.1) 66.9 (6.7) 73.3 (9.8)
Weight men (kg) 48.7 (4.6) 53.4 (4.3) 57.4 (4.5) 61.4 (4.6) 65.1 (5.0) 69.1 (5.2) 73.0 (5.8) 80.5 (10.1)
Weight women (kg) 42.5 (4.2) 47.0 (3.6) 50.5 (3.9) 53.6 (3.8) 57.3 (4.2) 60.6 (4.4) 63.9 (4.8) 70.9 (8.4)
Height (cm) 159.3 (8.2) 158.2 (7.3) 158.6 (7.4) 158.3 (7.3) 158.5 (7.4) 157.9 (7.5) 158.1 (7.8) 156.2 (7.9)
Height men (cm) 167.2 (7.2) 166.0 (6.5) 165.9 (6.2) 166.0 (6.0) 165.6 (6.1) 165.3 (6.1) 165.2 (6.3) 164.1 (6.8)
Height women (cm) 156.7 (6.7) 155.8 (5.7) 155.7 (5.7) 155.3 (5.3) 155.3 (5.4) 154.7 (5.5) 154.6 (5.8) 153.5 (6.2)
Body mass index 17.3 (1.0) 19.3 (0.4) 20.8 (0.4) 22.2 (0.4) 23.7 (0.4) 25.2 (0.5) 26.7 (0.4) 30.0 (2.8)
Education (% secondary) 34.8 37.3 36.6 34.2 33.4 29.1 29.7 24.9
‘Any physical activity (%) 26.3 29.8 30.1 31.8 31.1 31.3 30.6 25.2
Alcoholic drinks/wk 0.4 (1.9) 0.4 (2.2) 0.5 (2.5) 0.4 (2.2) 0.4 (2.1) 0.4 (2.1) 0.5 (2.6) 0.5 (3.0)
¥Hypertension (%) 10.2 12.9 16.4 21.4 26.6 31.3 35.5 42.2
1Prevalent disease (%) 10.4 9.4 10.9 11.5 13.7 13.9 15.0 18.1
Ever-smokers, N=15,485
N 1,590 1,860 2,590 2,585 2,513 1,834 1,100 1,413
Age 59.5 (7.9) 58.2 (8.1) 58.0 (7.9) 57.9 (8.1) 57.3 (7.8) 57.2 (7.9) 57.2 (7.8) 56.4 (7.8)
Sex (% women) 17.9 14.8 13.0 15.6 12.4 12.5 13.1 18.1
Weight (kg) 46.7 (5.2) 52.0 (4.8) 55.9 (4.9) 59.9 (5.4) 64.1 (5.7) 68.0 (5.9) 71.7 (6.2) 78.6 (9.8)
Weight men (kg) 47.9 (4.5) 52.9 (4.3) 56.9 (4.4) 61.1 (4.8) 65.1 (5.1) 69.1 (5.3) 72.8 (5.5) 80.2 (9.1)
Weight women (kg) 41.1 (4.6) 46.6 (3.8) 49.9 (3.8) 53.3 (3.7) 56.9 (4.4) 60.1 (4.2) 64.0 (4.9) 71.3 (9.5)
Height (cm) 164.5 (7.9) 164.0 (7.5) 163.9 (7.0) 163.8 (7.2) 164.2 (7.2) 163.9 (7.1) 163.7 (7.1) 162.3 (7.6)
Height men (cm) 166.4 (6.5) 165.5 (6.6) 165.3 (6.2) 165.5 (6.2) 165.5 (6.2) 165.3 (6.1) 165.0 (6.2) 164.3 (6.3)
Height women (cm) 155.7 (7.5) 155.2 (6.3) 155.0 (5.6) 154.8 (5.1) 154.7 (5.9) 154.1 (5.2) 154.7 (5.8) 153.2 (5.9)
Body mass index 17.2 (1.1) 19.3 (0.4) 20.8 (0.4) 22.3 (0.4) 23.7 (0.5) 25.3 (0.4) 26.7 (0.4) 29.8 (3.0)
Education (% secondary) 22.5 27.6 28.3 29.7 33.3 31.6 29.9 26.4
‘Any physical activity (%) 21.7 24.4 27.4 28.6 31.0 30.2 32.8 26.8
Alcoholic drinks/wk 2.8 (7.7) 2.6 (7.5) 2.5 (7.2) 2.1 (5.9) 2.1 (6.1) 1.9 (6.1) 2.1 (6.8) 1.9 (6.0)
¥Hypertension (%) 9.4 11.6 15.3 19.7 25.6 31.7 35.3 38.7
1Prevalent disease (%) 13.4 13.7 15.9 16.9 19.1 20.5 22.5 22.5
All values mean (standard deviation) or percentage of population (%).
1Prevalent disease= Self reported physician diagnosed baseline cardiovascular disease, diabetes mellitus or respiratory disease.
‘Any physical activity (%) = Report of any moderate or strenuous leisure physical activity.
¥Hypertension – Self reported physician diagnosed.
doi:10.1371/journal.pone.0014000.t001
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risk of lung cancers in smokers relative to normal and under
weight. [31] Related, overweight and obese people with
established cardiovascular disease, have been shown to have a
better prognosis compared with non-overweight/non-obese pa-
tients. [32] Similarly, our results in participants aged 65 and
greater suggest that the lowest risk for mortality is in the BMI
range 23–24.4 kg/m
2. These different associations between BMI
and mortality in older participants and ever and current smokers is
a topic in need of further investigation. It also suggests many
different immunological, physiological and metabolic pathways
play an important role positively or aversely depending on body
weight. [32–34]
The question of BMI and mortality has received significant
attention in Western populations, [3] but significantly less research
has addressed the topic in Asian populations. The Shanghai
Women’s Health study found a monotonic association between
baseline BMI and all-cause and cause-specific (CVD and cancer)
mortality with the optimum level of the BMI range in non-
smokers, without prevalent disease, and follow up greater than
three years being ,24.4, as risk increased significantly above this
level compared to the referent of BMI’s,22.2. [7] Gu et al. [8]
examined the question in a nationally representative sample of
Chinese men and women aged 40 years or older. Their data show
the range of BMI not associated with increased risk of mortality
being 24–26.9 in a healthy sub-sample of non-smokers, non-heavy
drinkers and no prevalent disease.
In a Korean cohort of men and women aged 30–95 years, [9] a
J-shaped association was observed for all cause mortality
independent of smoking status in persons aged less than 64. For
participants greater than 64 years of age at baseline there was no
association between BMI and mortality. A J-shaped association
was also observed in cancer deaths, but a monotonic linear
association was observed in cardiovascular disease with the lowest
risk at BMI’s,18.5. Our results are comparable to this study in the
age range less than 64 for all-cause mortality and cause specific
trends; however, we did not have an extended upper age range at
baseline, which may explain our different findings in this group. In
a similar Korean cohort of women [6] a U-shaped association was
observed with increased risk of mortality in BMI’s,21 and
BMI’s$27.0 compared to the referent group of BMI=21–22 in
the model adjusting for smoking status and accounting for deaths
early in the follow up time. We observed similar results in non-
smokers, but with a downward shift of an optimum BMI on the
spectrum from 21–22 to 18.5–19.9 in Singaporean Chinese.
In a Japanese population of men and women aged 40–59 years,
[5] risk increased in men with BMI’s,23, but not higher BMI’s
after excluding the first 5 years of follow up and thorough
adjustment including smoking status, compared to BMI’s 23–24.9
(middle BMI category). In the comparative group of women
BMI’s,19 and .30 displayed an increased risk. A similar
association was observed in never-smoking women. In non-
smoking men the only increased risk was at BMI’s,19, but this
point estimate should be interpreted cautiously due to having a
small number of cases. In a cohort study of Chinese men in
Shanghai aged 45–64 lifetime never-smokers with BMI’s,18.5
and .26.0 had an increased risk of mortality. In ever-smokers and
current smokers there was no association. Our main results are
comparable in non-smokers, however we found significant
associations in both ever and current smokers.
In summary, the studies examining BMI and mortality in East
and Southeast Asian populations present somewhat diverging
optimum levels of BMI for lowest all-cause mortality. The nature
of the association varies ranging from monotonic to J or U shaped,
to nearly a reverse J-shape in Japanese men. [5] These
inconsistencies are likely due to different methodological ap-
proaches, as well as different limitations across the studies. One
methodological aspect that could help in comparability and
interpretation of future studies of Asian populations is stratification
on smoking status and clear presentation of age stratified data
where BMI is a relevant surrogate measure of adiposity.
Incorporating these methodological approaches may better inform
Figure 1. Hazard ratios of cause-specific mortality according to BMI. Hazard ratios of cause specific mortality in non-smokers without
reported prevalent disease and excluding deaths occurring within 5 years of baseline (N=30,538). Models adjusted for age, sex, year of enrollment,
dialect, education, dietary pattern score and physical activity. Points represent hazard ratio (HR) point estimate and error bars represent 95%
confidence intervals. P for linear association for cardiovascular disease =0.0001. P trend for linear association for cancer =0.04. Respective mortality
counts for cancer and cardiovascular mortality by BMI (,18.5, 18.5–19.9, 20–21.4, 21.5–22.9, 23–24.4, 24.5–25.9, 26–27.4, $27.5): Cancer (58, 75, 130,
146, 146, 112, 64, 117), Cardiovascular disease (46, 39, 96, 139, 111, 99, 72, 95). Respective age & sex standardized mortality rates per 10,000 years
follow up: Cancer (23, 18, 20, 20, 21, 21, 20, 29) and Cardiovascular disease (18, 9, 15, 19, 16, 19, 23, 23).
doi:10.1371/journal.pone.0014000.g001
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in Asian adults. Objective choice of a referent group is another
consideration that will help with comparability. Life course data
on BMI and other measures in an Asian population would be
ideal. Absent those data, consideration of the recent history as well
as differences between and within the different populations of Asia
in interpretation of the BMI-mortality association may still be
informative.
In relation to public health and medical recommendations on
relative weight, our data provide evidence that Chinese Southeast
Asians distribute differently across the BMI spectrum vs. Western
populations and thus categorizing their population level risk differs
as the optimum relative weight is shifted to the left on the BMI
spectrum. Applying Western based population cut-points catego-
rizing overweight (.25.0 kg/m
2) and obesity (.30.0 kg/m
2)t o
Asian populations such as this Singapore population appears
inappropriate. As more data on the subject of adiposity and health
is gathered in all populations, it is becoming clearer that optimum
relative weight (BMI) for health and longevity may function in a
somewhat narrow range. [3] Yet, this remains controversial as
BMI often behaves as a non-linear continuum of risk for chronic
disease and mortality, and the nature of the association varies
Figure 2. Hazard ratios of mortality incorporating BMI groups ,18.5 kg/m
2. Hazard ratios of all cause and cause specific mortality
incorporating BMI groups less than 18.5 kg/m
2 in non-smokers without reported prevalent disease and excluding deaths occurring within 5 years of
baseline (N=30,538); and adjusted for age, sex, year of enrollment, dialect, education, dietary pattern score and physical activity. Points represent
hazard ratio (HR) point estimate and error bars represent 95% confidence intervals. P trend for quadratic association for all cause mortality=0.0002. P
trend for quadratic association for cardiovascular disease =0.0002. P trend for linear association for cancer =0.04.
doi:10.1371/journal.pone.0014000.g002
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strates. This risk needs to be considered with other health
behaviors, socioeconomic, ethnic and geographic context in
relation to health, as well as age considerations. Our data support
a lower range of BMI cut-points in Southeast and East Asian
populations relative to Western populations; however these differ
by smoking and age status making it difficult to provide scientific
rationale for a blanket population recommendation for BMI cut-
points.
Limitations of our study include incomplete data on mental
health conditions, other chronic health conditions such as COPD,
cirrhosis and some neurodegenerative diseases at baseline. Further
considerations include the use of self-reported height, weight and
other demographic and lifestyle data. Nonetheless, BMI by self
report has been shown to be highly valid in a number of
populations. [10] Yet, misclassification and measurement error of
height and weight need to be considered as possible influences on
the results. Additional measures of body habitus may complement
BMI in this population and contribute further to our understand-
ing; as well as multiple assessments of relative weight over time in
the etiology and epidemiology of body composition and mortality.
Strengths of our study include thorough assessment of potential
lifestyle and demographic confounders of the BMI-mortality
association, a large sample size and ample amount of events
combined with a long follow up time. These study characteristics
allowed us to stratify on important confounders and mediators and
address these areas more thoroughly than previous studies on
similar Asian populations. The participants are also representative
of the source population and mortality assessment is virtually
complete.
In conclusion, independent of age or BMI, smoking greatly
increases the rate of mortality and influences the association
between BMI and mortality. In non-smokers below the age of 65
the optimum level of BMI in relation to the lowest rate and risk of
all-cause mortality appears to be between 18.5 and 21.4 kg/m
2.
For non-smokers over age 65 the corresponding optimal range of
BMI with respect to all-cause mortality appears to be between 21.5
and 24.4 kg/m
2. Our findings contribute to the science behind
public health considerations on the appropriate and optimal range
of relative weight in some Asian populations where a higher
proportion of BMI values fall in a lower range compared to
Western populations.
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dialect, education, dietary pattern score and physical activity. Points represent HR point estimate and error bars represent 95% confidence intervals. P
value for interaction between age and BMI=0.0001. Respective age & sex standardized mortality rates per 10,000 years follow up: Age,65 (48, 38, 28,
33, 40, 37, 39, 40, 51), Age 65+ (257, 219, 190, 194, 168, 161, 175, 226, 198).
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